Publications

Trends in immunology

Parental leave in immunology-2.

01-05-2026

European radiology experimental

¹⁹F MRI radiomic features: in vitro and in vivo repeatability.

16-03-2026

Cell reports. Medicine

Liver metastases dampen IL18-driven γδ T cell activity and immunotherapy responsiveness in colorectal cancer.

17-02-2026

Nature

Fasting boosts breast cancer therapy efficacy via glucocorticoid activation.

01-01-2026

Trends in cancer

Myeloid cell path to malignancy: insights into liver cancer.

01-06-2025

STAR protocols

Protocol for studying macrophage lipid crosstalk with murine tumor cells.

20-12-2024

Nature reviews. Immunology

Defining myeloid-derived suppressor cells.

01-12-2024

Cell

P-stalk ribosomes act as master regulators of cytokine-mediated processes.

27-11-2024

Nature reviews. Cancer

Macrophages and T cells in metabolic disorder-associated cancers.

01-11-2024

Cancer cell

Architecture sets the path: Breast cancer subtypes differently shape the early brain metastatic niche.

14-10-2024

Cell

Macrophage-mediated myelin recycling fuels brain cancer malignancy.

19-09-2024

Nature communications

Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.

22-03-2024

Cancer discovery

Cancer Evolution: A Multifaceted Affair.

12-01-2024

Trends in immunology

Uniting innate and adaptive immunity in glioblastoma; an α-CTLA-4 quest.

01-12-2023

BJR open

How to 19F MRI: applications, technique, and getting started.

13-11-2023

Cancer cell

Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity.

12-06-2023

Molecular oncology

Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma.

01-06-2023

Nature cancer

CD103⁺ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8⁺ T cell activation in glioblastoma.

01-05-2023

Cell

Macrophages at the interface of the co-evolving cancer ecosystem.

13-04-2023

Clinical and translational radiation oncology

Study protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG) - A phase I trial.

01-03-2023

Nature

Single-cell spatial immune landscapes of primary and metastatic brain tumours.

01-02-2023

eLife

Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of hepatocellular carcinoma.

19-01-2023

Cell reports. Medicine

Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis.

15-11-2022

Seminars in cancer biology

Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play.

01-11-2022

Neuro-oncology

Glioblastoma scRNA-seq shows treatment-induced, immune-dependent increase in mesenchymal cancer cells and structural variants in distal neural stem cells.

01-09-2022

Current oncology reports

Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature.

01-03-2022

Nature cancer

Challenges and opportunities in 2021.

01-12-2021

Nature

EGFR activation limits the response of liver cancer to lenvatinib.

01-07-2021

Current protocols

Multiparametric Analyses of Hepatocellular Carcinoma Somatic Mouse Models and Their Associated Tumor Microenvironment.

01-06-2021

Science translational medicine

Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance.

15-07-2020

Cell

Mapping the Uncharted Territories of Human Brain Malignancies.

25-06-2020

Frontiers in immunology

Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers.

16-10-2019

Nature

Inducing and exploiting vulnerabilities for the treatment of liver cancer.

01-10-2019

Cell

The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.

08-08-2019

ACS nano

A Carbon Nanotube Optical Reporter Maps Endolysosomal Lipid Flux.

28-11-2017

Parental leave in immunology-2.

¹⁹F MRI radiomic features: in vitro and in vivo repeatability.

Liver metastases dampen IL18-driven γδ T cell activity and immunotherapy responsiveness in colorectal cancer.

Fasting boosts breast cancer therapy efficacy via glucocorticoid activation.

Myeloid cell path to malignancy: insights into liver cancer.

Protocol for studying macrophage lipid crosstalk with murine tumor cells.

Defining myeloid-derived suppressor cells.

P-stalk ribosomes act as master regulators of cytokine-mediated processes.

Macrophages and T cells in metabolic disorder-associated cancers.

Architecture sets the path: Breast cancer subtypes differently shape the early brain metastatic niche.

Macrophage-mediated myelin recycling fuels brain cancer malignancy.

Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.

Cancer Evolution: A Multifaceted Affair.

Uniting innate and adaptive immunity in glioblastoma; an α-CTLA-4 quest.

How to 19F MRI: applications, technique, and getting started.

Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity.

Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma.

CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma.

Macrophages at the interface of the co-evolving cancer ecosystem.

Study protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG) - A phase I trial.

Single-cell spatial immune landscapes of primary and metastatic brain tumours.

Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of hepatocellular carcinoma.

Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis.

Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play.

Glioblastoma scRNA-seq shows treatment-induced, immune-dependent increase in mesenchymal cancer cells and structural variants in distal neural stem cells.

Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature.

Challenges and opportunities in 2021.

EGFR activation limits the response of liver cancer to lenvatinib.

Multiparametric Analyses of Hepatocellular Carcinoma Somatic Mouse Models and Their Associated Tumor Microenvironment.

Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance.

Mapping the Uncharted Territories of Human Brain Malignancies.

Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers.

Inducing and exploiting vulnerabilities for the treatment of liver cancer.

The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.

A Carbon Nanotube Optical Reporter Maps Endolysosomal Lipid Flux.

This site uses cookies

CD103⁺ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8⁺ T cell activation in glioblastoma.